Ted Tenthoff is a managing director and senior research analyst at Piper Jaffray, focused on the drug discovery sector of the biotech industry. He was ranked No. 2 stock picker in biotechnology by the 2012 Wall Street Journal “Best on the Street” survey and was ranked No. 1 stock picker for the life science tools and services sector in the 2006 Starmine Analyst Awards. Prior to joining Piper Jaffray in 2003, he covered the genomics sector at Robertson Stephens & Company and was a medical technology analyst at Lehman Brothers. Tenthoff received a bachelor’s degree in international relations from the University of Pennsylvania.